A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancerscRNA/TCR-seq analysis of 234 anti-PD-1-treated tumors identified immune heterogeneity associated with short-term pathological response and long-term recurrence-free survival.scRNA/TCR-seq analysis of 234 anti-PD-1-treated tumors identified immune heterogeneity associated with short-term pathological response and long-term recurrence-free survival.Zedao Liu, Zhenlin Yang, Junqi Wu, Wenjie Zhang, Yuxuan Sun, Chao Zhang, Guangyu Bai, Li Yang, Hongtao Fan, Yawen Chen, Lei Zhang, Benyuan Jiang, Xiaoyan Liu, Xiaoshi Ma, Wei Tang, Chang Liu, Yang Qu, Lixu Yan, Deping Zhao, Yilong Wu, Shun He, Long Xu, Lishan Peng, Xiaowei Chen, Bolun Zhou, Liang Zhao, Zhangyi Zhao, Fengwei Tan, Wanting Zhang, Dingcheng Yi, Xiangjie Li, Qianqian Gao, Guangjian Zhang, Yongjie Wang, Minglei Yang, Honghao Fu, Yongjun Guo, Xueda Hu, Qingyuan Cai, Lu Qi, Yufei Bo, Hui Peng, Zhigang Tian, Yunlang She, Chang Zou, Linnan Zhu, Sijin Cheng, Yi Zhang, Wenzhao Zhong, Chang Chen, Shugeng Gao, Zemin Zhanghttps://www.cell.com/cell/fulltext/S0092-8674(25)00291-0?rss=yeshttp://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignMarch 27, 2025

Powered by WPeMatico